Although mutation of CTNNB1 is rare in BC [13], mounting evidence has revealed that the mutations in CTNNB1 are often associated with an upregulation of β-catenin and the pathogenesis of endometrial cancer and ovarian cancer [14]. This evidence concerns the gene CTNNB1 and ovarian cancer.